Subcutaneous bortezomib for multiple myeloma treatment: patients’ benefits

por Petrucci, Maria Teresa, Finsinger, Paola, Chisini, Marta, Gentilini, Fabiana
Publicado 2014

High Erk-1 activation and Gadd45a expression as prognostic markers in high risk pediatric haemolymphoproliferative diseases

por D'Angelo, Velia, Crisci, Stefania, Casale, Fiorina, Addeo, Raffaele, Giuliano, Maria, Pota, Elvira, Finsinger, Paola, Baldi, Alfonso, Rondelli, Roberto, Abbruzzese, Alberto, Caraglia, Michele, Indolfi, Paolo
Publicado 2009

Chronic Lymphocytic Leukemia (CLL) Patients Quality of Life (QoL): A Cross-Sectional Analysis of the Italian Experience in the Choice Study during the First Wave of the COVID-19 Pa...

por Tedeschi, Alessandra, Innocenti, Idanna, Albano, Francesco, Gozzetti, Alessandro, Levato, Luciano, Porrazzo, Marika, Reda, Gianluigi, Albi, Elisa, Chiarenza, Annalisa, Gualberti, Giuliana, Malgieri, Simona, Finsinger, Paola, Trentin, Livio
Publicado 2021

COVID-19 Pandemic Impact on Chronic Lymphocytic Leukemia (CLL) Patients' Preferences Towards Therapies: The Italian Experience (CHOICE Study)

por Molica, Stefano, Laurenti, Luca, Ghia, Paolo, Coscia, Marta, Cuneo, Antonio, Gaidano, Gianluca, Mauro, Francesca, Frustaci, Anna Maria, Vallisa, Daniele, Pane, Fabrizio, Gualberti, Giuliana, Iannella, Emilia, Finsinger, Paola, Caira, Morena, Sportoletti, Paolo
Publicado 2021